192 related articles for article (PubMed ID: 17072339)
1. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
[TBL] [Abstract][Full Text] [Related]
3. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
4. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
5. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
6. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
Capobianco AJ; Gilmore TD
Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
[TBL] [Abstract][Full Text] [Related]
7. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
8. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway.
Kalaitzidis D; Davis RE; Rosenwald A; Staudt LM; Gilmore TD
Oncogene; 2002 Dec; 21(57):8759-68. PubMed ID: 12483529
[TBL] [Abstract][Full Text] [Related]
9. cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain.
Fognani C; Rondi R; Romano A; Blasi F
Oncogene; 2000 Apr; 19(18):2224-32. PubMed ID: 10822372
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel.
Martin AG; Fresno M
J Biol Chem; 2000 Aug; 275(32):24383-91. PubMed ID: 10823840
[TBL] [Abstract][Full Text] [Related]
11. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
15. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.
Garbati MR; Gilmore TD
Gene Expr; 2008; 14(4):195-205. PubMed ID: 19110719
[TBL] [Abstract][Full Text] [Related]
16. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
Sarkar S; Gilmore TD
Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
[TBL] [Abstract][Full Text] [Related]
17. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
[TBL] [Abstract][Full Text] [Related]
18. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.
Bernard D; Monte D; Vandenbunder B; Abbadie C
Oncogene; 2002 Jun; 21(28):4392-402. PubMed ID: 12080470
[TBL] [Abstract][Full Text] [Related]
19. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
Gilmore TD; Gélinas C
Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
